IP Library Granted Patent US 11,426,360
Granted Patent B2
US 11,426,360 · App. 16/578,688 · Granted Aug 30, 2022

Pimarane diterpenoids for use in wound healing and angiogenesis

Inventors: Ehsan Jabbarzadeh (Columbia, SC); Sara Eslambolchimoghadam (Columbia, SC)
Assignees: University of South Carolina; TIGHitco, Inc.
A61K31/047A61K31/05A61P17/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,426,360
App. No.
16/578,688
Granted
Aug 30, 2022
Kind
B2
Abstract

Methods and compositions are described for use in encouraging angiogenesis and skin healing as may be utilized in wound treatment as well as in encouragement of angiogenesis in disease. Compositions include an effective amount of a natural pimarane diterpenoid extract of Hymenocrater elegans , or a derivative, analogue, or homolog thereof. Compounds based upon this natural extract have been found to be highly effective in vascular formation and skin closure while exhibiting low toxicity.

Claims (14)

1. A composition comprising a biocompatible carrier and a compound of structure (II):

2. The composition of claim 1 , wherein the composition is a component of a pharmaceutical appliance.

3. The composition of claim 2 , the pharmaceutical appliance comprising a suture, a staple, gauze, a bandage, a solid wound dressing, or an artificial skin.

4. The composition of claim 1 , the composition comprising a gel, a cream, a suspension, or an ointment.

5. The composition of claim 1 , wherein the composition is contained within a capsule.

6. The composition of claim 1 , the composition comprising the compound of structure (II) in an amount of about 50 wt. % or less by weight of the composition.

7. The composition of claim 1 , the composition comprising the compound of structure (II) in an amount of between about 0.00001% to about 5% of the composition.

8. The composition of claim 1 , the composition comprising the compound of structure (II) in an amount of from about 10 to about 100 micrograms per milliliter of the composition.

9. The composition of claim 1 , wherein the composition is ingestible.

10. The composition of claim 1 , wherein the composition is a topical composition.

11. The composition of claim 10 , wherein the composition is held in conjunction with a carrier or vehicle.

12. The composition of claim 11 , wherein the carrier comprises a foam, spray, salve, bio-adhesive, film, or fabric.

13. The composition of claim 1 , wherein the composition comprises one or more of: a filler, a diluent, a cleaning agent, a buffer, a preservative, a pH modifier, a toxicity modifier, a mechanical protectant, a chemical protectant, an adsorbent, an antioxidant, a viscosity modifier, an extender, an excipient, an astringent, an emollient, a demulcent, a humectant, an emulsifier, a transdermal delivery enhancing agent, a controlled-release agent, a dye or colorant, a stabilizer, or a lubricant.

14. The composition of claim 1 , wherein the composition is contained within a liposome or micelle.

Assignments (2)
CONFIRMATORY LICENSE Recorded Oct 23, 2019
From: UNIVERSITY OF SOUTH CAROLINA
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 050809/0404 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2019
From: JABBARZADEH, EHSAN; ESLAMBOLCHIMOGHADAM, SARA
To: UNIVERSITY OF SOUTH CAROLINA
Reel/Frame 050460/0974 →
Continuity (5)
Division 16004576 · Jun 11, 2018
Provisional Application 62518067 · Jun 12, 2017
Provisional Application 62634244 · Feb 23, 2018
Provisional Application 62651749 · Apr 3, 2018
Related Publication 20200016090A1 · Jan 16, 2020